Evaluating the Treatment of Diabetic Macular Edema with Aflibercept Based on a Regional Network of Ophthalmologic Care Givers

PURPOSE: In Austria, anti-VEGF therapies are reimbursed only in clinical settings. This study aimed to describe the outcome of a treat and extend regimen (TER) with aflibercept for diabetic macular edema (DME) in a network of practitioners. METHODS: In a prospective study over 36 months, patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Khalil, Haidar, Mariacher, Siegfried, Strauss, Rupert, Podkowinski, Dominika, Waser, Klemens, Bolz, Matthias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845034/
https://www.ncbi.nlm.nih.gov/pubmed/36660315
http://dx.doi.org/10.1155/2023/3165965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845034/
https://www.ncbi.nlm.nih.gov/pubmed/36660315
http://dx.doi.org/10.1155/2023/3165965

Ejemplares similares